Literature DB >> 11869554

[Microsatellite alterations on chromosome 9p21-22 in sporadic colorectal cancer].

Y Zhang1, M Lai.   

Abstract

OBJECTIVE: To study whether alteration of p16 plays an important role in the development of colorectal carcinomas and the relationship between the molecular changes of 9p21-22 chromosome subregion in sporadic colorectal cancers.
METHODS: To detect microsatellite instability (MSI) and loss of heterozygosity (LOH) by PCR, denatured-polyacrylamide gel-electrophoresis and silver staining (microsatellite DNA-PCR-silver staining method) and to compare the results with the clinopathological parameters.
RESULTS: Between MSI positive and negative cases and the clinopathological findings, some evidences found in the MSI positive group were as follows: (1) tendency towards younger patients (usually < 50 years in age, P < 0.05); (2) more frequently seen in mucoid carcinomas (P < 0.01).
CONCLUSIONS: Microsatellite DNA-PCR-silver staining method is very sensitive in detecting even a tiny change of a single base. MSI occured in the selected microsatellite loci of different subregions and different chromosomes might be different in significance, therefore, a right choice of the suitable loci for studying the microsatellite changes is important. Since the frequency of loss of heterozygosity at 9p21-22 is low (merely 8.42%), it is considered that p16 is not closely associated with the development of sporadic colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11869554

Source DB:  PubMed          Journal:  Zhonghua Bing Li Xue Za Zhi        ISSN: 0529-5807


  2 in total

Review 1.  Reg gene family and human diseases.

Authors:  Yu-Wei Zhang; Liu-Song Ding; Mao-De Lai
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

2.  Expression of tumor related genes NGX6, NAG-7, BRD7 in gastric and colorectal cancer.

Authors:  Xiao-Mei Zhang; Xiao-Yan Wang; Shou-Rong Sheng; Jie-Ru Wang; Jiang Li
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.